Position in GRAL
as of Jun 30, 2026
· filed Jul 24, 2026
Position Value
$25,874
+$6,288 QoQ
Shares Held
379
0.0% QoQ
Ownership
0.001%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#248
of 371 holders
Holding Since
Jun 2024
5 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in GRAL Over Time
Shares Held
Position Value (USD)
Position in Diagnostics & Research
Healthcare · as of Jun 30, 2026Crewe Advisors LLC holds $857,580 across 13 Diagnostics & Research names. GRAL ranks #4 (3.0% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | TMO |
Thermo Fisher Scientific Inc.
|
926 | $464,259 | |
| 2 | ADPT |
Adaptive Biotechnologies Corp
|
2,886 | $247,597 | |
| 3 | DHR |
Danaher Corp /De/
|
418 | $79,620 | |
| 4 | GRAL |
GRAIL, Inc.
This page
|
379 | $25,874 | |
| 5 | IQV |
Iqvia Holdings Inc.
|
54 | $10,433 | |
| 6 | A |
Agilent Technologies, Inc.
|
60 | $7,969 | |
| 7 | WAT |
Waters Corp /De/
|
18 | $6,750 | |
| 8 | CRL |
Charles River Laboratories International, Inc.
|
24 | $5,442 |
All Filings in GRAL
Export CSV
5 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $25,874 | 379 | Shares | Sole | 2026-07-24 | |
| 2026-03-31 | $19,586 | 379 | Shares | Sole | 2026-05-07 | |
| 2024-12-31 | $6,765 | 379 | Shares | Sole | 2025-01-27 | |
| 2024-09-30 | $5,559 | 404 | Shares | Sole | 2024-11-12 | |
| 2024-06-30 | $6,209 | 404 | Shares | Sole | 2024-07-29 | |
| No filing history on record for this holder in this stock. | ||||||